ストックスクリーナーアプリを入手
15.02
3.54%
-0.5271
前日終値:
$15.55
開ける：
$15.8
24時間の取引高:
225.06K
Relative Volume:
0.53
時価総額：
$931.68M
収益：
-
当期純損益:
$-41.43M
株価収益率:
-19.02
EPS:
-0.79
ネットキャッシュフロー:
$-39.97M
1週間 パフォーマンス:
+13.29%
1か月 パフォーマンス:
+4.82%
6か月 パフォーマンス:
-3.10%
1年 パフォーマンス:
+67.04%
1日の値動き範囲:
$14.71
$15.84
1週間の範囲:
$13.50
$19.00
52週間の値動き範囲:
$7.98
$20.50
Gh Research Plc Stock (GHRS) Company Profile
GHRS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
15.02 | 964.56M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.77 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
795.08 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.88 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
800.58 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
338.20 | 35.45B | 4.98B | 69.59M | 525.67M | 0.5197 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-13 | 開始されました | Needham | Buy |
| 2025-06-04 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-03-13 | 開始されました | Guggenheim | Buy |
| 2025-03-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-02-13 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-08-16 | 開始されました | H.C. Wainwright | Buy |
| 2022-06-16 | 開始されました | ROTH Capital | Buy |
すべてを表示
Gh Research Plc (GHRS) 最新ニュース
Will GH Research PLC (1KA) stock profit from fiscal stimulusStability vs Neutral Overview & lightweight options for faster days - ulpravda.ru
Assessing GH Research (GHRS) Valuation After FDA Lifts Clinical Hold On GH001 IND - Sahm
Is GH Research PLC (1KA) stock protected from inflationTrade Ideas & Low Risk Entry Point Tips - ulpravda.ru
Why analysts maintain buy rating on GH Research PLC (1KA) stock2025 Market Overview & Low Risk Profit Maximizing Plans - ulpravda.ru
Published on: 2026-01-09 02:32:55 - ulpravda.ru
How strong is GH Research PLC stock balance sheet2025 Valuation Update & Weekly High Conviction Ideas - ulpravda.ru
Quarterly Recap: What dividend safety score for GH Research PLC stock2025 Top Gainers & Weekly High Conviction Trade Ideas - ulpravda.ru
GH Research to Present Six-Month Safety and Efficacy Data on Inhaled GH001 in Depression at 2026 ACNP Meeting - TipRanks
Assessing GH Research (GHRS) Valuation After FDA Lifts Clinical Hold On GH001 Trials - Yahoo Finance UK
Stock market today: S&P 500, Nasdaq futures rise, WTI fluctuates following US strike on Venezuela—GH Research, Vertiv Holdings, Nukkleus in focus - MSN
Why Is GHRS Stock Rising Today? - Asianet Newsable
What drives GH Research PLC stock priceDividend Reinvestment Plans & Outstanding Capital Tips - earlytimes.in
Why is GHRS stock rising today? - MSN
Will GH Research PLC (1KA) stock gain from green policies2026 world cup usa national team round of 32 playmakers pressing system odds analysis tactical review - ulpravda.ru
GH Research (NASDAQ:GHRS) Stock Price Down 9.2%Should You Sell? - MarketBeat
GH Research stock price target raised to $29 from $19 at Needham - Investing.com Nigeria
GH Research stock rises as FDA lifts clinical hold on GH001 - Investing.com Australia
GH Research stock jumps as Canaccord raises price target on FDA hold lift - Investing.com
GHRS Stock Sees Significant Price Target Increase by Needham | G - GuruFocus
GH Research (GHRS) Is Up 24.2% After FDA Lifts Hold On GH001 U.S. Trial Enrollment - simplywall.st
Hold lifted, as GH Research preps for pivotal GH-001 depression trial - BioWorld MedTech
GH Research stock rating reiterated as Buy by TD Cowen - Investing.com Nigeria
GH Research says FDA lifts clinical hold on GH001 - TipRanks
GH Research stock rises as FDA lifts clinical hold on inhaled 5-MeO-DMT By Investing.com - Investing.com South Africa
Dow Jumps 800 Points; ISM Manufacturing PMI Falls In December - Benzinga
GH Research (NASDAQ:GHRS) Shares Gap UpTime to Buy? - MarketBeat
GH Research stock rises as FDA lifts clinical hold on inhaled 5-MeO-DMT - Investing.com Australia
GH Research stock rises as Stifel reiterates Buy rating after clinical hold lifted By Investing.com - Investing.com South Africa
Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday - Benzinga
US Stocks Higher; Dow Jumps 250 Points - Benzinga
GH Research stock rises as Stifel reiterates Buy rating after clinical hold lifted - Investing.com Nigeria
Why Is GH Research Stock Soaring Monday?GH Research (NASDAQ:GHRS) - Benzinga
Why GH Research Is Rising In Pre-market? - Nasdaq
Stock Market Today: S&P 500, Nasdaq, WTI Crude Futures Advance After US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus (UPDATED) - Benzinga
Stock Market Today: S&P 500, Nasdaq, WTI Crude Futures Advance After US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus (UPDATED) - Benzinga
Gh Research shares jump 44% premarket after US FDA lifts clinical hold on depression drug trials - MarketScreener
GHRS: Needham Reiterates Buy Rating and $19 Price Target | GHRS Stock News - GuruFocus
GH Research surges as FDA lifts clinical hold on depression therapy - Seeking Alpha
GH Research (NASDAQ:GHRS) Receives Buy Rating from Needham & Company LLC - MarketBeat
GH Research Says FDA Lifted Clinical Hold on Investigational New Drug Application for GH001; Shares Rise Pre-Bell - marketscreener.com
GH Research Wins FDA Clearance to Advance GH001 for Treatment-Resistant Depression - TipRanks
GH Research stock soars after FDA lifts clinical hold on GH001 By Investing.com - Investing.com South Africa
GH Research stock soars after FDA lifts clinical hold on GH001 - Investing.com Australia
GH Research stock grabs retail spotlight ahead of FDA update on depression treatment - MSN
GH Research : Corporate Presentation - marketscreener.com
NextEra Energy, GH Research And 3 Stocks To Watch Heading Into Monday - Benzinga
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026 - The Manila Times
FDA clears next-step testing of fast-acting drug for tough-to-treat depression - Stock Titan
Stock Market Today: S&P 500, Nasdaq Futures Rise, WTI Fluctuates Following US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus - Benzinga
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
GH Research Holdings Inc (NASDAQ:GHRS) Nasdaq Composite ETF Biotech Scope - Kalkine Media
Gh Research Plc (GHRS) 財務データ
収益
当期純利益
現金流量
EPS
0.86%
大文字化:
|
ボリューム (24 時間):